VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds
Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence
Anti-Estrogen Drug Therapy Reduces Risk of Invasive Breast Cancer In Older Women
Gene Therapy Shows Positive Results In Phase III Trial
New Genetic Test Approved For Breast Cancer Patients
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health